Skip to main content

Table 1 Characteristics of the patients

From: Excellent survival of pathological N0 small cell lung cancer patients following surgery

Characteristics

N = 196(%)

Age, median(range)

63(36–84)

Gender, N(%)

 

 Male

167(85.2)

 Female

29(14.7)

Respiratory risk, n (%)

 

 Active smoker

149(76.0)

 Never smoker

47(23.9)

Cancer description

 

 Median size cm (min–max)

2.8(0.7–11.2)

Surgery, n(%)

 

 Video-assisted thoracoscope surgery

47(23.9)

 Thoracotomy

149(76.0)

Range of resection, n (%)

 

 PNEUM

10(5.1)

 SLE

3(1.5)

 BILOB

20(10.2)

 LOB

144(73.4)

 SEG

10(5.1)

 WED

9(4.5)

pT staging, n (%)

 

 pT1

105(53.6)

 pT2

67(34.2)

 pT3

19(9.7)

 pT4

5(2.6)

pN staging, n (%)

 

 pN0

95(48.5)

 pN1

36(18.4)

 pN2

65(33.2)

pTNM staging, n (%)

 

 IA

65(33.2)

 IB

17(8.7)

 IIA

6(3.1)

 IIB

39(19.9)

 IIIA

54(27.6)

 IIIB

15(7.6)

cT staging, n (%)

 

 pT1

104(53.1)

 pT2

53(27.0)

 pT3

14(7.1)

 pT4

6(3.1)

 Unknown

19(9.7)

cN staging, n (%)

 

 pN0

86(43.9)

 pN1

37(18.9)

 pN2

54(27.6)

 Unknown

19(9.7)

cTNM staging, n (%)

 

 IA

52(26.5)

 IB

19(9.7)

 IIA

6(3.1)

 IIB

39(19.9)

 IIIA

56(28.6)

 IIIB

5(2.6)

 Unknown

19(9.7)

Postoperative therapy

 

 Non-adjuvant therapy

58(29.6)

 Adjuvant chemotherapy

75(38.3)

 Adjuvant chemoradiotherapy

63(32.1)

Time from diagnosis to surgery (days)

30(5–719)

BMI(kg/m2)

24.2(17.0–35.3)

ECOG score

 

 1

16

 0

180

  1. Values are presented as n (%)
  2. Unknown: Data was not available
  3. PNEUM pneumonectomy, SLE Sleeve resection, BILOB Bilateral lobectomy, LOB Lobectomy, SEG Segmentectomy, WED Wedge resection, BMI Body mass index, ECOG Eastern Cooperative Oncology Group